Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline. Issue 34 (1st December 2022)
- Record Type:
- Journal Article
- Title:
- Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline. Issue 34 (1st December 2022)
- Main Title:
- Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
- Authors:
- Mao, Jun J.
Ismaila, Nofisat
Bao, Ting
Barton, Debra
Ben-Arye, Eran
Garland, Eric L.
Greenlee, Heather
Leblanc, Thomas
Lee, Richard T.
Lopez, Ana Maria
Loprinzi, Charles
Lyman, Gary H.
MacLeod, Jodi
Master, Viraj A.
Ramchandran, Kavitha
Wagner, Lynne I.
Walker, Eleanor M.
Bruner, Deborah Watkins
Witt, Claudia M.
Bruera, Eduardo - Abstract:
- Abstract : PURPOSE: The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. METHODS: The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: The literature search identified 227 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS: Among adult patients, acupuncture should be recommended for aromatase inhibitor–related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for otherAbstract : PURPOSE: The aim of this joint guideline is to provide evidence-based recommendations to practicing physicians and other health care providers on integrative approaches to managing pain in patients with cancer. METHODS: The Society for Integrative Oncology and ASCO convened an expert panel of integrative oncology, medical oncology, radiation oncology, surgical oncology, palliative oncology, social sciences, mind-body medicine, nursing, and patient advocacy representatives. The literature search included systematic reviews, meta-analyses, and randomized controlled trials published from 1990 through 2021. Outcomes of interest included pain intensity, symptom relief, and adverse events. Expert panel members used this evidence and informal consensus to develop evidence-based guideline recommendations. RESULTS: The literature search identified 227 relevant studies to inform the evidence base for this guideline. RECOMMENDATIONS: Among adult patients, acupuncture should be recommended for aromatase inhibitor–related joint pain. Acupuncture or reflexology or acupressure may be recommended for general cancer pain or musculoskeletal pain. Hypnosis may be recommended to patients who experience procedural pain. Massage may be recommended to patients experiencing pain during palliative or hospice care. These recommendations are based on an intermediate level of evidence, benefit outweighing risk, and with moderate strength of recommendation. The quality of evidence for other mind-body interventions or natural products for pain is either low or inconclusive. There is insufficient or inconclusive evidence to make recommendations for pediatric patients. More research is needed to better characterize the role of integrative medicine interventions in the care of patients with cancer. Additional information is available at https://integrativeonc.org/practice-guidelines/guidelines and www.asco.org/survivorship-guidelines . … (more)
- Is Part Of:
- Journal of clinical oncology. Volume 40:Issue 34(2022)
- Journal:
- Journal of clinical oncology
- Issue:
- Volume 40:Issue 34(2022)
- Issue Display:
- Volume 40, Issue 34 (2022)
- Year:
- 2022
- Volume:
- 40
- Issue:
- 34
- Issue Sort Value:
- 2022-0040-0034-0000
- Page Start:
- 3998
- Page End:
- 4024
- Publication Date:
- 2022-12-01
- Subjects:
- Oncology -- Periodicals
Cancer -- Periodicals
Oncology
Medical Oncology
Cancérologie -- Périodiques
Cancer -- Périodiques
Cancérologie
Cancer
Oncology
Oncologia
Càncer
Periodicals
616.994 - Journal URLs:
- http://www.jco.org/ ↗
http://jco.ascopubs.org/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1200/JCO.22.01357 ↗
- Languages:
- English
- ISSNs:
- 0732-183X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24600.xml